Haemonetics (HAE) Acquisitions (2010 - 2026)

Haemonetics (HAE) posted quarterly Acquisitions of $60.2 million for Q1 2026, up 3329.06% quarter-over-quarter from $1.8 million in Q3 2024.

Haemonetics (HAE) Acquisitions (2010 - 2026) Analysis & Trends

Haemonetics' Acquisitions history runs 10 years deep, the most recent figure standing at $60.2 million for Q1 2026.

In Q1 2026, Acquisitions changed N/A year-over-year to $60.2 million; the TTM figure through Mar 2026 stood at $60.2 million (down 60.12% YoY), while the FY2026 annual figure was $60.2 million, down 60.12% from the prior year.
Acquisitions for Q1 2026 stood at $60.2 million, up from $1.8 million in the prior quarter.
The five-year high for Acquisitions was $243.9 million in Q4 2023, with the low at $1.8 million in Q3 2024.
The 4-year median for Acquisitions is $104.7 million (2024), against an average of $116.5 million.
Peak annual rise in Acquisitions reached 14.0% in 2022, while the deepest fall reached 14.0% in 2022.
Haemonetics' Acquisitions stood at $2.8 million in 2022, then surged by 8456.21% to $243.9 million in 2023, then sank by 99.28% to $1.8 million in 2024, then surged by 3329.06% to $60.2 million in 2026.
Business Quant data shows HAE's Acquisitions at $60.2 million in Q1 2026, $1.8 million in Q3 2024, and $149.2 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn	-
2	Stryker	129.93 Bn	126.46 Bn	4.50 Bn	437.00 Mn
3	Medtronic	120.49 Bn	111.27 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	74.60 Bn	74.06 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.68 Bn	48.42 Bn	1.35 Bn	-
6	Dexcom	34.78 Bn	32.84 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	-4.00 Mn
8	Koninklijke Philips	26.44 Bn	23.12 Bn	4.55 Bn	-3.49 Mn
9	Steris	23.18 Bn	22.69 Bn	684.20 Mn	16.00 Mn
10	Haemonetics	4.93 Bn	4.70 Bn	202.80 Mn	-

Download Data